Clark Eliana's Form 4 filing
Intellia Therapeutics, Inc. (NTLA) · filed Jan 5, 2024
- Accession no.
- 0000950170-24-002502
- Filed
- Jan 5, 2024
- Trade date
- Jan 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $136.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Clark ElianaCIK 0001914448 | Officer (EVP, Chief Technical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2024 | Common Stock | SSaleDisposed | −307 | $30.12 | −$9,246.84 | 45,146 | Direct | |
| Jan 3, 2024 | Common Stock | SSaleDisposed | −4,301 | $29.46 | −$126,707.46 | 40,845 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.